Allergy Diagnostics and Therapeutics Market Size, Trends and Insights By Product Type (Instruments, Consumables, Therapeutics, Others), By Test Type (Skin Tests, Blood Tests, Provocation Tests:, Elimination Diet Tests, Others), By Allergen Type (Inhaled Allergens, Food Allergens, Drug Allergens, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Reports Description
As per the current market research conducted by the CMI Team, the global Allergy Diagnostics and Therapeutics Market is expected to record a CAGR of 8.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 38,713.6 Million. By 2033, the valuation is anticipated to reach USD 78,036.1 Million.
The allergy diagnostics and therapeutics market encompasses products and services used for the identification, management, and treatment of allergic conditions. Diagnostic tools include skin tests, blood tests (serology), and provocation tests, which detect allergen-specific immune responses.
Therapeutic options range from medications, such as antihistamines and corticosteroids, to allergen-specific immunotherapy (AIT), aimed at desensitizing patients to allergens.
This market is driven by increasing allergy prevalence globally, advancements in diagnostic technologies, and a shift towards personalized medicine. It serves a critical role in improving patient outcomes by providing accurate diagnosis, effective management strategies, and ongoing advancements in treatment modalities.
Allergy Diagnostics and Therapeutics Market – Significant Growth Factors
The Allergy Diagnostics and Therapeutics Market presents significant growth opportunities due to several factors:
- Increasing Prevalence of Allergic Diseases: The rising incidence of allergic conditions worldwide, attributed to environmental factors and genetic predispositions, drives demand for advanced diagnostic tools and effective therapeutic solutions.
- Technological Advancements in Diagnostics: Ongoing innovations in allergy testing technologies, such as enhanced sensitivity and specificity of blood tests and improved accuracy of skin tests, propel market growth by enabling precise allergy diagnosis.
- Shift towards Personalized Medicine: The growing adoption of personalized treatment approaches based on individual allergen profiles enhances the demand for tailored therapeutics like allergen-specific immunotherapy (AIT), driving market expansion.
- Increasing Healthcare Expenditure: Higher healthcare spending globally supports investments in allergy diagnostics and therapeutics, facilitating improved patient access to diagnostic services and innovative treatment options.
- Expansion in Emerging Markets: Opportunities lie in expanding market presence in emerging regions where allergy prevalence is rising, supported by improving healthcare infrastructure and increasing awareness about allergic diseases.
- Integration of Digital Health Technologies: The integration of telehealth platforms and remote monitoring solutions presents opportunities to enhance patient engagement, improve diagnostic accuracy, and streamline allergy management processes, thereby fostering market growth.
Allergy Diagnostics and Therapeutics Market – Mergers and Acquisitions
The Allergy Diagnostics and Therapeutics Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Allergy Diagnostics and Therapeutics Market include:
- In 2023, ALK received FDA approval to expand the use of ODACTRA, a sublingual immunotherapy tablet, for adolescents aged 12 through 17 with house dust mite-induced allergic rhinitis. This approval signifies a broader application of ODACTRA in treating allergic conditions among younger patients.
- In 2022, Thermo Fisher Scientific’s ImmunoCAP blood tests for wheat and sesame allergies have received FDA approval. These in vitro diagnostic tests detect specific antibodies, distinguishing between wheat sensitization and cross-reactivity with grasses. This advancement aims to reduce unnecessary dietary restrictions for patients with allergies.
- In 2022, STAT Medical launched its first product line featuring at-home allergy test kits. These user-friendly kits allow individuals to self-screen for common food and respiratory allergies through a simple finger prick, enhancing accessibility to allergy testing outside of traditional healthcare settings.
These mergers and acquisitions helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Allergy Diagnostics and Therapeutics Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Allergy Diagnostics and Therapeutics Market | Aesthetics Injectables Market | Embolic Protection Device Market |
| CAGR 8.1% (Approx) | CAGR 9.8% (Approx) | CAGR 7.6% (Approx) |
| USD 78,036.1 Million by 2033 | USD 35,976.2 Million by 2033 | USD 3,562.2 Million by 2033 |
Allergy Diagnostics and Therapeutics Market – Significant Threats
The Allergy Diagnostics and Therapeutics Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
- Stringent Regulatory Requirements: Complex and evolving regulatory landscapes for diagnostic tests and therapeutic products pose challenges in market entry and compliance, potentially delaying innovation and market introduction.
- High Development Costs: The substantial investment required for research and development of new allergy diagnostics and therapeutics, coupled with stringent clinical trial requirements, can deter smaller companies and startups from entering the market.
- Competitive Market Landscape: Intense competition among key players and the presence of well-established brands with extensive product portfolios can lead to pricing pressures and reduced profit margins, affecting market sustainability.
- Limited Reimbursement Policies: Inconsistent reimbursement policies for allergy diagnostics and therapeutics across different regions and healthcare systems may limit patient access to innovative treatments, impacting market adoption.
- Allergen Complexity and Diversity: The vast diversity of allergens and their variability across populations pose challenges in developing comprehensive diagnostic panels and universally effective therapeutic solutions, hindering market standardization and adoption.
Category-Wise Insights
By Product Type:
- Instruments: Diagnostic instruments include advanced technologies like immunoassay analyzers and PCR instruments, crucial for accurate allergy testing. Trends involve continuous advancements in automation, enhancing testing efficiency and accuracy, and the integration of artificial intelligence for data analysis.
- Consumables: Consumables encompass assay kits, reagents, and test strips used in allergy diagnostics. Trends include the development of multiplex assays for simultaneous detection of multiple allergens and the shift towards rapid, point-of-care testing solutions.
- Therapeutics: Therapeutics in allergy management include medications (antihistamines, corticosteroids), allergen-specific immunotherapy (AIT), and biologics. Trends focus on personalized medicine, with tailored treatments based on individual allergen profiles, and the development of novel biologic therapies targeting specific immune pathways.
- Others: Other products include allergy vaccines, allergy testing software, and accessories. Trends involve advancements in allergy vaccine formulations to improve efficacy and safety profiles, and the integration of digital health technologies for remote monitoring and management of allergic conditions.
By Test Type
- Skin Tests: Skin tests involve applying allergens to the skin and observing reactions, aiding in identifying allergic sensitivities. Trends include advancements in standardized allergen extracts and improved test accuracy, enhancing diagnostic reliability and patient comfort.
- Blood Tests: Blood tests detect allergen-specific antibodies in the bloodstream, providing a quantitative measure of allergic response. Trends focus on enhanced sensitivity and specificity, automation of testing procedures, and the development of multiplex assays for comprehensive allergy profiling.
- Provocation Tests: Provocation tests involve controlled exposure to allergens through inhalation, ingestion, or contact to confirm allergic reactions under medical supervision. Trends include the refinement of protocols for safety and accuracy, utilization in research settings for understanding allergy mechanisms and adapting methods for diverse allergens.
- Elimination Diet Tests: Elimination diet tests involve removing suspected allergens from the diet and reintroducing them systematically to identify food allergies or intolerances. Trends include integration with digital health platforms for tracking symptoms, personalized dietary guidance based on allergen profiles, and the use of biomarkers to validate dietary exclusions.
- Others: This category includes various emerging and specialized allergy diagnostic methods, such as molecular diagnostics, component-resolved diagnostics (CRD), and point-of-care testing (POCT). Trends encompass the development of rapid and portable diagnostic tools, expanding applications in pediatric and geriatric populations, and integration with telemedicine for remote allergy management.
By Allergen Type
- Inhaled Allergens: Inhaled allergens like pollen, dust mites, and pet dander are common triggers of respiratory allergies. Diagnostic tests include skin prick tests and specific IgE blood tests. Therapeutic options range from antihistamines to allergen immunotherapy, targeting symptom relief and desensitization.
- Food Allergens: Food allergens such as peanuts, tree nuts, and shellfish can cause severe allergic reactions. Diagnosis involves elimination diets, oral food challenges, and IgE blood tests. Treatment includes allergen avoidance and emergency medications like epinephrine.
- Drug Allergens: Drug allergies to medications like penicillin and aspirin are diagnosed through skin tests, drug provocation tests, and specific IgE blood tests. Management involves avoidance and alternative medications.
- Others: Other allergens like latex and insect venoms are diagnosed using skin tests and specific IgE blood tests. Treatment includes allergen avoidance and immunotherapy for severe reactions.
By End Users
- Hospitals & Clinics: Hospitals and clinics serve as primary points of care for allergy patients, offering diagnostic testing and treatment options. Trends include the integration of advanced allergy diagnostic technologies, such as molecular diagnostics and point-of-care testing, to improve patient outcomes and streamline allergy management processes.
- Diagnostic Laboratories: Diagnostic laboratories specialize in conducting allergy tests, including skin prick tests and blood tests, to identify allergens. Trends include the automation of testing processes and the adoption of high-throughput platforms to enhance diagnostic accuracy and efficiency, meeting the increasing demand for allergy diagnostics.
- Research Institutes: Research institutes play a critical role in advancing allergy diagnostics and therapeutics through innovative research and development. Trends include collaborations with industry stakeholders to develop novel diagnostic assays and therapeutic modalities, leveraging genomic and proteomic technologies for personalized allergy treatments.
- Others: Other segments encompass academic institutions and specialty allergy clinics, which provide specialized care and contribute to allergy research. Trends include the expansion of telemedicine services for remote patient consultations and the development of digital health solutions to improve allergy management and patient education.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 38,713.6 Million |
| Projected Market Size in 2033 | USD 78,036.1 Million |
| Market Size in 2023 | USD 35,812.8 Million |
| CAGR Growth Rate | 8.1% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product Type, Test Type, Allergen Type, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Allergy Diagnostics and Therapeutics Market – Regional Analysis
The Allergy Diagnostics and Therapeutics Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
- North America: North America leads in allergy diagnostics and therapeutics, driven by advanced healthcare infrastructure and high allergy prevalence. Trends include the adoption of personalized medicine approaches, such as precision diagnostics and targeted therapies, and increasing investments in advanced allergy research and development.
- Europe: Europe emphasizes standardized allergy management and advancements in allergen-specific immunotherapy (AIT). Trends include stringent regulatory standards for allergy diagnostics, expanding telehealth services for remote allergy consultations, and growing collaborations between academic institutions and pharmaceutical companies for innovative allergy treatments.
- Asia-Pacific: Asia-Pacific shows rapid market growth fueled by rising allergy incidence and improving healthcare access. Trends include the adoption of cost-effective allergy testing solutions, such as point-of-care diagnostics, and the expansion of allergy management programs in urban centers. Increasing partnerships with global healthcare providers drive the adoption of advanced allergy therapies in the region.
- LAMEA (Latin America, Middle East, and Africa): LAMEA region experiences growing awareness and adoption of allergy diagnostics and therapeutics. Trends include government initiatives to improve allergy healthcare services, such as allergy awareness campaigns and training programs for healthcare professionals. Expansion in healthcare infrastructure and increasing investments in allergy research contribute to market growth in the region.
Competitive Landscape – Allergy Diagnostics and Therapeutics Market
The Allergy Diagnostics and Therapeutics Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Danaher Corporation
- Hitachi Chemical Diagnostics Inc.
- Omega Diagnostics Group PLC
- bioMérieux SA
- Hycor Biomedical Inc.
- Lincoln Diagnostics Inc.
- Stallergenes Greer PLC
- HAL Allergy Group
- Biomay AG
- Indoor Biotechnologies Inc.
- R-Biopharm AG
- ALK-Abelló A/S
- Leti Pharma GmbH
- Others
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
New players in the allergy diagnostics and therapeutics market, such as AllerGenis and BioTek Instruments, have embraced innovation by focusing on developing advanced diagnostic tools and personalized treatment options. These companies leverage technologies like molecular diagnostics and AI-driven algorithms to enhance allergy testing accuracy and treatment efficacy.
Key players dominating the market include Thermo Fisher Scientific, Siemens Healthineers, and Danaher Corporation. They maintain market leadership through extensive R&D investments, comprehensive product portfolios covering a wide range of allergens, and strategic partnerships with healthcare providers to ensure widespread adoption of their diagnostics and therapies globally. Their established market presence and robust distribution networks further solidify their dominance in allergy management solutions.
The Allergy Diagnostics and Therapeutics Market is segmented as follows:
By Product Type
- Instruments
- Consumables
- Therapeutics
- Others
By Test Type
- Skin Tests
- Blood Tests
- Provocation Tests:
- Elimination Diet Tests
- Others
By Allergen Type
- Inhaled Allergens
- Food Allergens
- Drug Allergens
- Others
By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Allergy Diagnostics and Therapeutics Market, (2024 – 2033) (USD Million)
- 2.2 Global Allergy Diagnostics and Therapeutics Market: snapshot
- Chapter 3. Global Allergy Diagnostics and Therapeutics Market – Industry Analysis
- 3.1 Allergy Diagnostics and Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing Prevalence of Allergic Diseases
- 3.2.2 Technological Advancements in Diagnostics
- 3.2.3 Shift towards Personalized Medicine
- 3.2.4 Increasing Healthcare Expenditure
- 3.2.5 Expansion in Emerging Markets
- 3.2.6 Integration of Digital Health Technologies.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Test Type
- 3.7.3 Market Attractiveness Analysis By Allergen Type
- 3.7.4 Market Attractiveness Analysis By End User
- Chapter 4. Global Allergy Diagnostics and Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Allergy Diagnostics and Therapeutics Market: company market share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Allergy Diagnostics and Therapeutics Market – Product Type Analysis
- 5.1 Global Allergy Diagnostics and Therapeutics Market Overview: By Product Type
- 5.1.1 Global Allergy Diagnostics and Therapeutics Market Share, By Product Type, 2023 and 2033
- 5.2 Instruments
- 5.2.1 Global Allergy Diagnostics and Therapeutics Market by Instruments, 2024 – 2033 (USD Million)
- 5.3 Consumables
- 5.3.1 Global Allergy Diagnostics and Therapeutics Market by Consumables, 2024 – 2033 (USD Million)
- 5.4 Therapeutics
- 5.4.1 Global Allergy Diagnostics and Therapeutics Market by Therapeutics, 2024 – 2033 (USD Million)
- 5.5 Others
- 5.5.1 Global Allergy Diagnostics and Therapeutics Market by Others, 2024 – 2033 (USD Million)
- 5.1 Global Allergy Diagnostics and Therapeutics Market Overview: By Product Type
- Chapter 6. Global Allergy Diagnostics and Therapeutics Market – Test Type Analysis
- 6.1 Global Allergy Diagnostics and Therapeutics Market Overview: By Test Type
- 6.1.1 Global Allergy Diagnostics and Therapeutics Market Share, By Test Type, 2023 and 2033
- 6.2 Skin Tests
- 6.2.1 Global Allergy Diagnostics and Therapeutics Market by Skin Tests, 2024 – 2033 (USD Million)
- 6.3 Blood Tests
- 6.3.1 Global Allergy Diagnostics and Therapeutics Market by Blood Tests, 2024 – 2033 (USD Million)
- 6.4 Provocation Tests
- 6.4.1 Global Allergy Diagnostics and Therapeutics Market by Provocation Tests, 2024 – 2033 (USD Million)
- 6.5 Elimination Diet Tests
- 6.5.1 Global Allergy Diagnostics and Therapeutics Market by Elimination Diet Tests, 2024 – 2033 (USD Million)
- 6.6 Others
- 6.6.1 Global Allergy Diagnostics and Therapeutics Market by Others, 2024 – 2033 (USD Million)
- 6.1 Global Allergy Diagnostics and Therapeutics Market Overview: By Test Type
- Chapter 7. Global Allergy Diagnostics and Therapeutics Market – Allergen Type Analysis
- 7.1 Global Allergy Diagnostics and Therapeutics Market Overview: By Allergen Type
- 7.1.1 Global Allergy Diagnostics and Therapeutics Market Share, By Allergen Type, 2023 and 2033
- 7.2 Inhaled Allergens
- 7.2.1 Global Allergy Diagnostics and Therapeutics Market by Inhaled Allergens, 2024 – 2033 (USD Million)
- 7.3 Food Allergens
- 7.3.1 Global Allergy Diagnostics and Therapeutics Market by Food Allergens, 2024 – 2033 (USD Million)
- 7.4 Drug Allergens
- 7.4.1 Global Allergy Diagnostics and Therapeutics Market by Drug Allergens, 2024 – 2033 (USD Million)
- 7.5 Others
- 7.5.1 Global Allergy Diagnostics and Therapeutics Market by Others, 2024 – 2033 (USD Million)
- 7.1 Global Allergy Diagnostics and Therapeutics Market Overview: By Allergen Type
- Chapter 8. Global Allergy Diagnostics and Therapeutics Market – End User Analysis
- 8.1 Global Allergy Diagnostics and Therapeutics Market Overview: By End User
- 8.1.1 Global Allergy Diagnostics and Therapeutics Market Share, By End User, 2023 and 2033
- 8.2 Hospitals & Clinics
- 8.2.1 Global Allergy Diagnostics and Therapeutics Market by Hospitals & Clinics, 2024 – 2033 (USD Million)
- 8.3 Diagnostic Laboratories
- 8.3.1 Global Allergy Diagnostics and Therapeutics Market by Diagnostic Laboratories, 2024 – 2033 (USD Million)
- 8.4 Research Institutes
- 8.4.1 Global Allergy Diagnostics and Therapeutics Market by Research Institutes, 2024 – 2033 (USD Million)
- 8.5 Others
- 8.5.1 Global Allergy Diagnostics and Therapeutics Market by Others, 2024 – 2033 (USD Million)
- 8.1 Global Allergy Diagnostics and Therapeutics Market Overview: By End User
- Chapter 9. Allergy Diagnostics and Therapeutics Market – Regional Analysis
- 9.1 Global Allergy Diagnostics and Therapeutics Market Regional Overview
- 9.2 Global Allergy Diagnostics and Therapeutics Market Share, by Region, 2023 & 2033 (USD Million)
- 9.3. North America
- 9.3.1 North America Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.3.1.1 North America Allergy Diagnostics and Therapeutics Market, by Country, 2024 – 2033 (USD Million)
- 9.3.1 North America Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.4 North America Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033
- 9.4.1 North America Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033 (USD Million)
- 9.5 North America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033
- 9.5.1 North America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033 (USD Million)
- 9.6 North America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033
- 9.6.1 North America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033 (USD Million)
- 9.7 North America Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033
- 9.7.1 North America Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033 (USD Million)
- 9.8. Europe
- 9.8.1 Europe Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.8.1.1 Europe Allergy Diagnostics and Therapeutics Market, by Country, 2024 – 2033 (USD Million)
- 9.8.1 Europe Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.9 Europe Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033
- 9.9.1 Europe Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033 (USD Million)
- 9.10 Europe Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033
- 9.10.1 Europe Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033 (USD Million)
- 9.11 Europe Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033
- 9.11.1 Europe Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033 (USD Million)
- 9.12 Europe Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033
- 9.12.1 Europe Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033 (USD Million)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.13.1.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Country, 2024 – 2033 (USD Million)
- 9.13.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.14 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033
- 9.14.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033 (USD Million)
- 9.15 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033
- 9.15.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033 (USD Million)
- 9.16 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033
- 9.16.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033 (USD Million)
- 9.17 Asia Pacific Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033
- 9.17.1 Asia Pacific Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033 (USD Million)
- 9.18. Latin America
- 9.18.1 Latin America Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.18.1.1 Latin America Allergy Diagnostics and Therapeutics Market, by Country, 2024 – 2033 (USD Million)
- 9.18.1 Latin America Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.19 Latin America Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033
- 9.19.1 Latin America Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033 (USD Million)
- 9.20 Latin America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033
- 9.20.1 Latin America Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033 (USD Million)
- 9.21 Latin America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033
- 9.21.1 Latin America Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033 (USD Million)
- 9.22 Latin America Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033
- 9.22.1 Latin America Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033 (USD Million)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.23.1.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Country, 2024 – 2033 (USD Million)
- 9.23.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, 2024 – 2033 (USD Million)
- 9.24 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033
- 9.24.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Product Type, 2024 – 2033 (USD Million)
- 9.25 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033
- 9.25.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Test Type, 2024 – 2033 (USD Million)
- 9.26 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033
- 9.26.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by Allergen Type, 2024 – 2033 (USD Million)
- 9.27 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033
- 9.27.1 The Middle-East and Africa Allergy Diagnostics and Therapeutics Market, by End User, 2024 – 2033 (USD Million)
- Chapter 10. Company Profiles
- 10.1 Thermo Fisher Scientific Inc.
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Siemens Healthineers AG
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Danaher Corporation
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Hitachi Chemical Diagnostics Inc.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Omega Diagnostics Group PLC
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 bioMérieux SA
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Hycor Biomedical Inc.
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Lincoln Diagnostics Inc.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Stallergenes Greer PLC
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 HAL Allergy Group
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Biomay AG
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Indoor Biotechnologies Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 R-Biopharm AG
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 ALK-Abelló A/S
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Leti Pharma GmbH
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Others.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.1 Thermo Fisher Scientific Inc.
List Of Figures
Figures No 1 to 35
List Of Tables
Tables No 1 to 102
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Danaher Corporation
- Hitachi Chemical Diagnostics Inc.
- Omega Diagnostics Group PLC
- bioMérieux SA
- Hycor Biomedical Inc.
- Lincoln Diagnostics Inc.
- Stallergenes Greer PLC
- HAL Allergy Group
- Biomay AG
- Indoor Biotechnologies Inc.
- R-Biopharm AG
- ALK-Abelló A/S
- Leti Pharma GmbH
- Others
FAQs
The key factors driving the Market are Increasing Prevalence of Allergic Diseases, Technological Advancements in Diagnostics, Shift towards Personalized Medicine, Increasing Healthcare Expenditure, Expansion in Emerging Markets, Integration of Digital Health Technologies.
The “Instruments” category dominated the market in 2023.
The key players in the market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Hitachi Chemical Diagnostics Inc., Omega Diagnostics Group PLC, bioMérieux SA, Hycor Biomedical Inc., Lincoln Diagnostics Inc., Stallergenes Greer PLC, HAL Allergy Group, Biomay AG, Indoor Biotechnologies Inc., R-Biopharm AG, ALK-Abelló A/S, Leti Pharma GmbH, Others.
“North America” had the largest share in the Allergy Diagnostics and Therapeutics Market.
The global market is projected to grow at a CAGR of 8.1% during the forecast period, 2024-2033.
The Allergy Diagnostics and Therapeutics Market size was valued at USD 38,713.6 Million in 2024.